Investigating liver fibrosis and its role in liver cancer development
Molecular Magnetic Resonance of Hepatic Fibrogenesis
This study is looking for better ways to spot liver cancer early by using new imaging techniques to check for liver damage, which could help people with chronic liver diseases know if they're at higher risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11039970 on NIH RePORTER |
What this research studies
This research focuses on identifying high-risk populations for hepatocellular carcinoma (HCC) by developing noninvasive imaging techniques to assess liver fibrosis. The team has created molecular probes that can accurately measure the extent of liver fibrosis and fibrogenesis, which are critical factors in predicting the progression to HCC. By improving the ability to predict which patients are at risk, the research aims to enhance screening and chemoprevention strategies for liver cancer. Patients with chronic liver diseases may benefit from these advancements in early detection and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic liver diseases who are at high risk for developing hepatocellular carcinoma.
Not a fit: Patients without chronic liver conditions or those who are not at risk for liver cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening methods and preventive treatments for patients at risk of liver cancer.
How similar studies have performed: Previous research has shown promise in using molecular imaging techniques for assessing liver conditions, indicating that this approach may be effective.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Caravan, Peter D — Massachusetts General Hospital
- Study coordinator: Caravan, Peter D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.